160 related articles for article (PubMed ID: 36646953)
21. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
24. Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.
Ito R; Nakamura Y; Sunakawa H; Fujiwara H; Hojo H; Nakamura N; Fujita T; Yano T; Daiko H; Akimoto T; Yoshino T; Kojima T
Esophagus; 2022 Oct; 19(4):645-652. PubMed ID: 35900683
[TBL] [Abstract][Full Text] [Related]
25. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang X; Li M; Meng X; Kong L; Zhang Y; Wei G; Zhang X; Shi F; Hu M; Zhang G; Yu J
Radiat Oncol; 2014 Feb; 9():64. PubMed ID: 24571804
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial.
Ai D; Ye J; Wei S; Li Y; Luo H; Cao J; Zhu Z; Zhao W; Lin Q; Yang H; Zheng X; Zhou J; Huang G; Li L; Li J; Zhang Z; Zhou G; Gu D; Du M; Mo M; Jia H; Zhang Z; Zhao K
JAMA Netw Open; 2022 Feb; 5(2):e220120. PubMed ID: 35188552
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
28. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
Li Q; Zhu S; Li S; Deng W
Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
[TBL] [Abstract][Full Text] [Related]
29. Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
Chen X; Zhang Y; Zhou X; Wang M; Na F; Zhou L; Xu Y; Zou B; Xue J; Liu Y; Gong Y
Front Oncol; 2023; 13():1274924. PubMed ID: 37886166
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma.
Sakanaka K; Ishida Y; Fujii K; Itasaka S; Miyamoto S; Horimatsu T; Muto M; Mizowaki T
Radiat Oncol; 2018 Jan; 13(1):7. PubMed ID: 29347960
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy and Increased Prescription Dose in Esophageal Squamous Cell Cancer: A Retrospective Study.
Pan X; Liao M; Ma H; Jiang X; Huang H; Wei M; Li Q
Biomed Res Int; 2021; 2021():3834040. PubMed ID: 33628778
[TBL] [Abstract][Full Text] [Related]
33. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.
Onozawa M; Nihei K; Ishikura S; Minashi K; Yano T; Muto M; Ohtsu A; Ogino T
Radiother Oncol; 2009 Aug; 92(2):266-9. PubMed ID: 18952308
[TBL] [Abstract][Full Text] [Related]
34. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
35. Incidental nodal irradiation in patients with esophageal cancer undergoing (chemo)radiation with 3D-CRT or VMAT.
Peschel DP; Düsberg M; Peeken JC; Kaiser JC; Borm KJ; Sommer K; Combs SE; Münch S
Sci Rep; 2022 Dec; 12(1):22333. PubMed ID: 36567356
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world.
Wang HC; Huang X; Chen J; Li Y; Cong Y; Qu BL; Feng SQ; Liu F
World J Gastroenterol; 2023 Nov; 29(41):5641-5656. PubMed ID: 38077159
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma.
Wang S; Ji B; Li C; Han W; Wang X; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Bi N; Deng L; Wang W; Zhang T; Xiao Z
Esophagus; 2022 Oct; 19(4):717-725. PubMed ID: 35760946
[TBL] [Abstract][Full Text] [Related]
39. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer].
Zhu SC; Li QF; Zhang XY; Deng WZ; Song CY; Wang X; Yan K
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1040-1047. PubMed ID: 33342161
[No Abstract] [Full Text] [Related]
40. Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial.
Li H; Fang Y; Gu D; Du M; Zhang Z; Sun L; Zhou G; Ye J
Radiat Oncol; 2022 Jun; 17(1):105. PubMed ID: 35681233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
